Long Covid Newsletter
Issue #29March 23, 20267 studies

Long COVID symptoms persist in 59% of healthcare workers 4 years after infection

Four years after the pandemic began, researchers are still tracking how long COVID affects people over time. This week brought new insights into everything from childhood treatments to the biological mechanisms that might explain why some people never fully recover.

πŸ• Long COVID symptoms linger for years in healthcare workers

  • Swiss researchers tracked 456 healthcare workers who caught the original SARS-CoV-2 strain and found that 41% still reported at least one long COVID symptom nearly 4 years later (median 47.5 months post-infection)

  • At 18.5 months after infection, 186 workers (40.8%) had long COVID symptoms, with fatigue affecting 22.8%, loss of smell/taste in 11.4%, and brain fog in 8.3%

  • Most symptoms declined over time, but among the 70 workers still participating at the final survey, 59% continued experiencing at least one persistent symptom

Why it matters: This suggests long COVID isn't just a temporary condition that resolves within monthsβ€”a substantial portion of people may deal with ongoing symptoms for years, which has major implications for workforce planning and healthcare resource allocation.

Top 20% journal πŸ”— Infection πŸ—“οΈ Mar 18

Key Findings

🩸 Early immune abnormalities may predict long COVID risk

  • Researchers used advanced immune profiling on blood samples from COVID patients and found distinct immune signatures between those who later developed long COVID versus those who didn't

  • People who eventually got long COVID showed early abnormalities in innate immune cells (dendritic cells and Ξ³Ξ΄ T cells) during their initial infection

  • Three months after hospital discharge, persistent changes were still visible in adaptive immune cells in patients who went on to develop long COVID

πŸ’‘ Early immune dysfunction during acute COVID may help identify who's at risk for developing long-term symptoms.
πŸ₯‰ Top 5% journal πŸ”— The Journal of infection πŸ—“οΈ Mar 19

πŸ’‰ COVID vaccines cut long COVID risk, but fatigue remains stubborn

  • Analysis of 756 German patients found that full vaccination (β‰₯2 doses) before infection reduced long COVID risk by 44% overall (OR 0.555)

  • Vaccines were particularly protective against respiratory symptoms (49% reduction) and cognitive issues (56% reduction)

  • However, vaccination showed no protective effect against fatigue symptoms (OR 0.917), suggesting this symptom may have different underlying mechanisms

πŸ’‘ Vaccines provide significant but incomplete protection against long COVID, with fatigue appearing to be driven by different biological pathways.
πŸ”— Mayo Clinic proceedings πŸ—“οΈ Mar 18

πŸ«€ Children with long COVID show measurable blood vessel damage

  • German researchers examined 37 pediatric long COVID patients and found significant microvascular damage compared to 46 healthy controls

  • Kids with long COVID had reduced blood vessel density (16.12 vs 19.38 mm/mmΒ²) and impaired blood flow in small vessels

  • Children with breathing problems showed the most severe vascular changes, suggesting damaged blood vessels might explain persistent respiratory symptoms

πŸ’‘ Long COVID in children involves actual physical damage to small blood vessels, not just lingering fatigue or psychological effects.
Top 20% journal πŸ”— European journal of pediatrics πŸ—“οΈ Mar 17

🧠 Multimodal treatment improves quality of life in long COVID patients

  • A primary care long COVID clinic tracked 150 patients with neurocognitive symptoms for 6 months using comprehensive treatment approaches

  • Patients received disease education plus combinations of rehabilitation therapy and targeted medications (44% got both, 22% rehab only, 16% drugs only)

  • Significant improvements were seen across all quality-of-life measures, with the biggest gains in physical functioning (+2.9 points), fatigue reduction (-4.9 points), and social functioning (+3.4 points)

πŸ’‘ Combining education, rehabilitation, and targeted medications may help long COVID patients regain function and reduce symptoms.
πŸ₯‰ Top 5% journal πŸ”— Journal of general internal medicine πŸ—“οΈ Mar 20

🧬 Three distinct immune clusters identified in long COVID

  • Scientists analyzed cytokine patterns in 289 COVID patients, 44 with long COVID, and 51 healthy controls using advanced statistical modeling

  • They identified three key immune clusters: local immune responses (IL-13, CCL7, IL-4), neuroinflammatory processes (IL-18, CCL2, IL-8), and blood vessel changes (sCD40L, growth factors)

  • The coordinated interactions between these clusters suggest long COVID involves multiple simultaneous biological processes rather than a single mechanism

πŸ’‘ Long COVID appears to involve at least three different immune pathways working together, which may explain why symptoms are so varied and persistent.
πŸ₯‰ Top 5% journal πŸ”— Frontiers in immunology πŸ—“οΈ Mar 16

πŸ₯ People with autoimmune diseases face higher long COVID risk

  • Analysis of 2.47 million patients found that those with pre-existing autoimmune diseases had nearly double the risk of smell/taste problems (OR 1.99) and hair loss (OR 1.96) after COVID

  • Patients with primary autoantibody-associated autoimmune diseases showed the highest risk for most long COVID symptoms

  • However, prior COVID vaccination significantly reduced long COVID risk in people with autoimmune diseases, with particularly strong protection in those with autoantibody conditions

πŸ’‘ Autoimmune patients should prioritize vaccination, as they face higher long COVID risk but get greater protection from vaccines.
πŸŽ–οΈ Top 10% journal πŸ”— Int J Infect Dis πŸ—“οΈ Mar 19

Implications

This week's research paints a picture of long COVID as a complex, multi-system condition with measurable biological changes that can persist for years. The good news: vaccines provide significant protection, and comprehensive treatment approaches show promise for improving patients' lives, even if the underlying mechanisms remain incompletely understood.

Studies in this issue

Primary sources used for this newsletter.

  1. Long-lasting COVID-19 symptoms in healthcare workers four years after original infection
    main storyInfection2026-03-18PMID 41845161
  2. Autoimmune Disease Linked to Higher Long COVID Risk but Previous Vaccination Offers Protection
    key findingInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2026-03-19PMID 41856465
  3. Long-lasting changes in T cells and early immune system imbalance as possible signs of Long COVID
    key findingThe Journal of infection2026-03-19PMID 41856437
  4. Poor small blood vessel flow and stiffer arteries in children with Long COVID
    key findingEuropean journal of pediatrics2026-03-17PMID 41840045
  5. COVID-19 vaccination and long COVID symptoms across different definitions and types
    key findingMayo Clinic proceedings2026-03-18PMID 41850429
  6. Key Patterns of Immune Proteins in COVID-19 and Long COVID
    key findingFrontiers in immunology2026-03-16PMID 41836412
  7. Changes over time in patients with thinking problems after COVID attending a specialized clinic
    key findingJournal of general internal medicine2026-03-20PMID 41857445

Continue reading

All Long Covid issues